Recent Post

hero image

Founders Should Understand Sales from the Start: Kent Summers

  • Nov 26, 2024
hero image

Tribute to Brian Flood Set for Today

  • Nov 24, 2024
hero image

Book Explores Frustrations of Today’s Manager

  • Nov 21, 2024

recent news

Genesis Names Ed Martin President and CEO

  • Oct 08, 2024
  • Carol Moreira

St. John’s innovation hub Genesis has appointed Ed Martin, formerly Director of the Memorial Centre for Entrepreneurship, its new President and Chief Executive Officer.

Before working as director at MCE, Martin co-founded and led Clockwork Fox

read more

DependBuild in TechStars

  • Oct 07, 2024
  • Carol Moreira

Dependbuild, the St. John's maker of cloud software that helps municipalities and infrastructure developers assess risks to construction projects, has been accepted into TechStars accelerator in Ohio State University in Columbus.

The accelerator

read more

The Future of Innovation Event Set for Friday

  • Oct 06, 2024
  • Carol Moreira

The University of New Brunswick's 2024 Future of Innovation Conference in Fredericton will focus on solutions for problems that are persistent throughout Canada and the world.

The annual conference, hosted by the university's J Herbert Smith Centre

read more

How Dash Hudson Scaled to 220 People

  • Oct 04, 2024
  • Avery Mullen

It was a willingness to pivot based on market feedback that helped propel Halifax-based Dash Hudson to an enterprise employing 220 people, but it may have been a resolute focus on human resources that made the business sustainable.

Audiences at

read more

Sparrow Closes $10M Funding Tranche

  • Oct 02, 2024
  • Peter Moreira

Having just closed $10 million in funding, Sparrow BioAcoustics is setting its sights on building the world’s biggest databank of cardiological recordings, and helping doctors and patients understand how that can help them.

Last week, the

read more

Mysa Investors Return with $11M

  • Oct 02, 2024
  • Peter Moreira

St. John’s-based Mysa has closed an $11 million round of funding, which is a continuation of the $20.3 million Series B round it announced in 2021.

The investors in the continuation round are all returning from the previous funding round: Climate

read more

Leach Celebrates New Award and Older Workers

  • Oct 01, 2024
  • Carol Moreira

As he mourns his late wife, educator Mary Kilfoil, Ed Leach focuses on their joint commitment to boosting entrepreneurship and employment among older workers. It’s an issue of fairness, but Leach stresses that prolonged working is also better for

read more

Best of Luck, Avery Mullen

  • Oct 01, 2024
  • Peter Moreira, Carol Moreira

We regret to say that Avery Mullen, who has served as our reporter for several years, is no longer with Entrevestor full-time.

We’re subject to the same economic realities as the rest of the news business, and unfortunately we had to give Avery

read more

Wellnify Signs 61-School Pilot Agreement

  • Sep 30, 2024
  • Avery Mullen

Two weeks after it won entry to a high-profile American accelerator, Halifax-based Wellnify has announced a partnership agreement with another Nova Scotia company, outdoor gym equipment-maker Outdoor-Fit Exercise Systems.

Under the deal, 61 schools

read more

Aurea Pre-Sells $405K of Revised Product

  • Sep 27, 2024
  • Avery Mullen

Two weeks after Dartmouth-based Aurea Technologies opened its Kickstarter campaign for the next generation of its portable wind turbines, the company has raised over 13 times its goal, as CEO Cat Adalay eyes deliveries in January or February.

The

read more

10 Companies Join Accelerate

  • Sep 26, 2024
  • Avery Mullen

Invest Nova Scotia has announced the 10 companies joining the latest cohort of its Accelerate startup program.

Now in its fourth year, Accelerate offers participating startups four months of business and technical training and $40,000 of funding.

read more

KardioDiagnostix Eyes Clinical Study

  • Sep 25, 2024
  • Avery Mullen

KardioDiagnostix, the Halifax maker of AI for analyzing paediatric heart murmurs, has expanded its research and development efforts via an agreement with a clinic in Toronto after gathering data from about 400 patients in Nova Scotia.

In

read more